| Literature DB >> 22385553 |
Michael Ibrahim1, Bassey Ussen, Alison Pottle, Mahmoud Barbir.
Abstract
Coronary artery disease remains a significant cause of morbidity and mortality in the Western world. High plasma Lp(a) concentrations are related to the risk of cardiovascular disease, but Lp(a) is rarely assayed and treated. We present the case of a 50-year-old gentleman with refractory angina, whose coronary disease continued to progress despite optimal medical and surgical therapy. We show that the aggressive reduction of Lp(a) successfully ameliorated the progression of coronary stenosis and provides effective and durable relief of symptoms. Copyright ÂEntities:
Mesh:
Substances:
Year: 2011 PMID: 22385553 DOI: 10.1016/j.jacl.2011.11.003
Source DB: PubMed Journal: J Clin Lipidol ISSN: 1876-4789 Impact factor: 4.766